ShivenBharatPatelMDMBA, FACP

PubMed

• Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer.
  Yeonjung Jo, Sonam Puri, Benjamin Haaland, Adriana M Coletta, Jonathan J Chipman
  Clinical Lung Cancer. 2024-10-09
• Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b ...
  Joel W Neal, Armando Santoro, Maria Gonzalez-Cao, Farah Louise Lim, Bruno Fang
  JTO Clinical and Research Reports. 2024-10-01
• 1 citations
  Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.
  Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, David J Kwiatkowski, Shiven Patel
  Lung Cancer. 2024-09-01

Journal Articles

• Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma  
  Kuzman JA, Stenehjem DD, Merriman J, Agarwal AM, Patel SB, Hahn AW, Alex A, Albertson D, Gill DM, Agarwal N, BMC Urology, 1/1/2017
• Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular en...  
  Bailey EB, Merriman J, Maughan B, Poole A, Tantravahi SK, Agarwal AM, Batten JA, Patel SB, Pal SK, Stenehjem DD, Agarwal N, Journal of Oncology Pharmacy Practice, 1/1/2017
• Myeloid Growth Factors, Version 22017, NCCN Clinical Practice Guidelines in Oncology  
  Crawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P, Dinner S, Fyan T, Gojo I, Griffiths EA, Hough S, Kloth DD, Kuter DJ, Lyman GH, Mably M, Mukherjee S..., Journal of the National Comprehensive Cancer Network, 1/1/2017
• Genomic analysis of adult B-ALL identifies potential markers of shorter survival  
  Patel S, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Reshmi S, Gastier-Foster JM, Schiffman JD, Miles RR, Leuk Res, 1/1/2017
• Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies  
  Patel SB, Stenehjem DD, Gill DM, Tantravahi SK, Agarwal AM, Hsu J, Vuong W, Pal SK, Agarwal N, Clinical Genitourinary Cancer, 1/1/2016
• Inherited variants in SULT1E1 and response to abiraterone acetate in men with metastatic castration refractory prostate cancer (mCRPC)  
  Agarwal N, Alex AB, Farnham JM, Patel SB, Gill D, Buckley TH, Stephenson RA, Cannon-Albright L, Journal of Urology, 1/1/2016
• Correlation of severity of hypothyroidism and survival outcomes in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor receptor tyros...  
  Bailey EB, Tantravahi SK, Poole AI, Agarwal AM, Straubhar AM, Batten JA, Patel SB, Wells CE, Stenehjem DD, Agarwal N, Clinical Genitourinary Cancer, 1/1/2015
• Survival outcomes and tumor IMP3 expression in patients with sarcomatoid metastatic renal cell carcinoma  
  Tantravahi SK, Albertson D, Agarwal AM, Ravulapati S, Poole AI, Patel SB, Hawatmeh JS, Straubhar AM, Liu T, Stenehjem DD, Agrawal N, Journal of Oncology, 1/1/2015
• Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer  
  Patel SB, Gill D, Garrido-Laguna I, Onco Targets Ther, 1/1/2015
• Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease [Letter to the ...  
  Patel SB, Rodgers GM, Haemophilia, 1/1/2014
• Response to nab-paclitaxel plus gemcitabine in a patient with primary resistance to FOLFIRINOX  
  Reese ZL, Patel SB, Stenejhem DD, Garrido-Laguna I, Journal of Gastrointestinal Cancer, 1/1/2014
• Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinibmeylate in conjunction with systemic and intratheca...  
  Patel SB, Gojo I, Tidwell ML, Sausville EA, Baer MR, Leuk Lymphoma, 1/1/2011
• Mitochondrial depolarization following hydrogen sulfide exposure in erythrocytes from a sulfide-tolerant marine invertebrate  
  Julian, D, April, KL, Patel, SB, Stein, JR., Wohlgemuth, SE, Journal of Experimental Biology, 1/1/2005
• Join now to see all

Abstracts/Posters

• Association of time from definitive therapy (DT) to start of androgen deprivation therapy (ADT) for metastatic disease and survival outcomes in men with new metastatic...
  Gill DM, Stenehjem DD, Cheng HH, Kessler ER, Hahn AW, Gupta S, Alex A, Patel SB, Chittoria N, Twardowski P, Vaishampayan UN, Agarwal N, Journal of Clinical Oncology, 1/1/2017
• Neutrophil-lymphocyte ratio (NLR) as a predictive biomarker for response to high dose interleukin 2 (HDIL-2) in patients with metastatic renal cell carcinoma (mRCC).
  Kuzman JA, Stenehjem DD, Patel SB, Merriman J, Gill DM, Hahn A, Agarwal AM, Gupta S, Albertson D, Alex A, Agarwal N, Journal of Clinical Oncology, 1/1/2016
• Association of single nucleotide polymorphisms (SNPs) in STS and SULT2B1 and response to androgen deprivation therapy (ADT) in men with advanced hormone sensitive pros...
  Agarwal N, Buckley TH, Farnham JM, Patel SB, Agarwal A, Tantravahi SK, Teerlink C, Albright FS, Stephenson RA, Alex A, Cannon-Albright LA, Clinical Cancer Research, 1/1/2016
• Association of single nucleotide polymorphism in four genes and response to androgen deprivation therapy (ADT) in men with advanced hormone sensitive prostate cancer (...
  Gill DM, Alex A, Farnham JM, Buckley TH, Patel SB, Agarwal AM, Teerlink C, Albright FS, Stephenson RA, Cannon-Albright LA, Agarwal N, Journal of Clinical Oncology, 1/1/2016
• Association of single nucleotide polymorphisms (SNPs) in SULT1E1 with response to treatment with abiraterone acetate (AA) in men with metastatic castration refractory ...
  Buckley TH, Alex A, Franham JM, Gill DM, Patel SB, Teerlink C, Albright FS, Stephenson RA, Cannon-Albright LA, Agarwal N, Journal of Clinical Oncology, 1/1/2016
• Risk of hepatotoxicity with concurrent statin and tyrosine kinase inhibitor (TKI) or mTOR inhibitor (mTORi) in patients with metastatic renal cell carcinoma (mRCC).
  Au TH, Bailey EB, Patel SB, Tantravahi SK, Agarwal N, Stenehjem DD, Journal of Clinical Oncology, 1/1/2016
• Effect of concomitant proton pump inhibitor (PPI) on effectiveness of tyrosine kinase inhibitor (TKI) in patients with metastatic renal cell carcinoma (mRCC).
  Au TH, Bailey EB, Patel SB, Tantravahi SK, Agarwal N, Stenehjem DD, Journal of Clinical Oncology, 1/1/2016
• Impact of prior definitive therapy on survival outcomes in men with new hormone-sensitive metastatic prostate cancer (mHSPC).
  Alex A, Stenehjem DD, Twardowski P, Cheng HH, Gill DM, Buckley H, Patel SB, Kessler ER, Chittoria N, Poudel A, Vaishampayan UN, Agarwal N, Journal of Clinical Oncology, 1/1/2016
• Impact of prior definitive therapy on survival outcomes in men with new hormone sensitive metastatic prostate cancer (mHSPC).
  Alex A, Stenehjem DD, Twardowski P, Cheng HH, Buckley TH, Gill DM, Patel SB, Vaishampayan U, Agarwal N, Journal of Clinical Oncology, 1/1/2016
• Association of single nucleotide polymorphisms (SNPs) in TPD52 gene with response to treatment with enzalutamide (ENZA) in men with metastatic castration refractory pr...
  Agarwal N, Heemers H, Farnham JM, Patel SB, Gill DM, Gupta S, Teerlink C, Stephenson RA, Alex A, Cannon-Albright LA, Journal of Clinical Oncology, 1/1/2016
• Genomic analysis of adult B-ALL identifies changes in copy number profile at relapse and IKZF1/CDKN2A co- deletion at diagnosis as a marker of shorter survival.
  Patel SB, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Reshmi SR, Gastier-Foster JM, Schiffman JD, Miles RR, Blood, 1/1/2015
• Long term response in metastatic renal cell carcinoma patients receiving first line therapy with vascular endothelial growth factor inhibitors with VEGF TKIs.
  Tantravahi SK, Patel SB, Ravulapati S, Batten JA, Merriman J, Stenehjem DD, Agarwal N, Journal of Clinical Oncology, 1/1/2015
• Exceptional responses in patients with upper gastrointestinal malignancies enrolled in first-in-man studies: 2002-20012.
  Reese ZL, Tometich D, Patel SB, Sharma S, Garrido-Laguna I, Journal of Clinical Oncology, 1/1/2015
• Exceptional responses in patients with metastatic colorectal cancer enrolled in first-in-man studies from 2002-2012.
  Patel SB, Tometich D, Reese ZL, Sharma S, Garrido-Laguna I, Journal of Clinical Oncology, 1/1/2015
• Comparative effectiveness of first line vascular endothelial growth factor inhibitor followed by second line therapy with either a VEGF-TKI or an mTOR inhibitor in pat...
  Patel SB, Stenehjem DD, Hsu J, Tantravahi SK, Gill D, Agarwal A, Batten JA, Agarwal N, Pal SK, Journal of Clinical Oncology, 1/1/2015
• Correlation of baseline serum testosterone (T) and serum prostate-specific antigen (PSA) at 7 months (7 mo PSA) in patients with new hormone sensitive metastatic prost...
  Patel SB, Buckley TH, Tantravahi SK, Batten JA, Stenehjem DD, Alex A, Agarwal N, Journal of Clinical Oncology, 1/1/2015
• Everolimus (EVE) versus temsirolimus (TEM) after first-line treatment with VEGF TKI in patients with metastatic renal cell carcinoma.
  Patel SB, Agarwal N, Hsu J, Tantravahi SK, Gill D, Vuong W, Batten JA, Stenehjem DD, Pal SK, Journal of Clinical Oncology, 1/1/2015
• Correlation of baseline serum testosterone and serum prostate-specific antigen at 7 months in patients with new hormone sensitive metastatic prostate cancer treated wi...
  Buckley TH, Patel SB, Tantravahi SK, Batten JA, Stenehjem DD, Alex A, Agarwal N, Journal of Clinical Oncology, 1/1/2015
• Germline predictors of response to androgen deprivation therapy in men with advanced prostate cancer.
  Agarwal N, Buckley TH, Farnham JM, Patel SB, Alex A, Teerlink C, Albright FS, Stephenson RA, Cannon-Albright LA, Journal of Clinical Oncology, 1/1/2015
• Association of single nucleotide polymorphisms in ESR1 and PRMT8 and response to treatment with abiraterone acetate in men with metastatic castration refractory prosta...
  Agarwal N, Alex A, Farnham JM, Patel SB, Tantravahi SK, Teerlink C, Albright FS, Stephenson RA, Cannon-Albright LA, Journal of Clinical Oncology, 1/1/2015
• IKZF1/CDKN2A Co-Deletion Predicts Shorter Survival in Adult B-ALL.
  Patel SB, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Schiffman JD, Miles RR, Cancer Research, 1/1/2015
• When macrophages attack!
  Torres M, Feurer M, Patel SB, Utah Chapter of the American College of Physicians Annual Meeting, Salt Lake City, UT, 1/1/2013
• Paralysis: An uncommon complication of hyperthyroidism.
  Patel SB, Tuan JC, Maryland Chapter of the American College of Physicians Annual Meeting, Baltimore, MD, 1/1/2011
• Subdural Hematomas in Patients with Acute Lymphoblastic Leukemia on Tyrosine Kinase Inhibitors.
  Patel SB, Tuan JC, Baer MR, American College of Physicians, Maryland Chapter Annual Meeting, Baltimore, MD, 1/1/2010
• Bilateral oculomotor nerve palsy in primary B-cell CNS lymphoma.
  Brescia T, Patel SB, Maryland Chapter of the American College of Physicians Annual Meeting, Baltimore, MD, 1/1/2009
• Join now to see all

Lectures

• Risk stratification using patient-reported outcomes (PROs) in patients (pts) with advanced cancer. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Oncologic Emergencies 
  1/1/2018
• Lung Cancer 
  Veterans Affairs Hospital, University of Utah - 1/1/2017
• Small Cell Lung Cancer 
  1/1/2017
• Hormonal Therapy in Cancer 
  1/1/2017
• Antimitotic Inhibitors and Antineoplastic Antibiotics 
  1/1/2017
• Platinums & Alkylators 
  1/1/2017
• Immunotherapy and Oncology 
  1/1/2017
• A Precision Approach to Lung Cancer Treatment. 
  Salt Lake City, UT - 1/1/2016
• A Multidisciplinary Approach to Lung Cancer. 
  Salt Lake City, UT - 1/1/2016
• The role of chemotherapy in head and neck cancers 
  University of Utah, Salt Lake City, UT - 1/1/2016
• Non-small Cell Lung Cancer 
  1/1/2016
• Alkylators & Platinums 
  1/1/2015
• Tyrosine Kinase Inhibitors 
  1/1/2015
• Monoclonal Ab & Protesasome Inhibitors 
  1/1/2015
• Crossroads in Oncology: Correlating Genotype to Phenotype 
  Huntsman Cancer Institute, Salt Lake City, UT - 1/1/2015
• Antiphospholipid Syndrome: A Bleeding Disorder or a Clottinf Disorder? 
  Huntsman Cancer Institute, Salt Lake City, UT - 1/1/2012
• The July Phenomenon: Are hospitals more dangerous in July? 
  University of Maryland, Baltimore, MD - 1/1/2011
• Hemangiomas of Infancy. 
  University of Florida College of Medicine, Gainesville, FL - 1/1/2007
• Mitochondrial injury induced by sulfide exposure in coelomocytes. 
  University of Florida, College of Liberal Arts and Sciences. Gainesville, FL - 1/1/2004
• Join now to see all